MedTrace Logo

650nm Low-level Red-light for Myopia Control and Prevention in Children

NCT05786586 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 572

Last updated 2024-09-25

No results posted yet for this study

Summary

A multicenter randomized controlled trial, evaluating the efficacy and safety of 650nm low-level red-light irradiation for myopia control and prevention in children. Participants included children(aged 6 to 12 years, spherical equivalent error of 0.5D or below) who are already myopic at recruitment, and those who are of Emmetropia or low hyperopia.

Conditions

  • Myopia

Interventions

DEVICE

650 nm low-level red-light

650 nm low-level red-light is a kind of laser, concentrated into a beam, to repeatedly irradiate the retina

Sponsors & Collaborators

  • Beijing Children's Hospital

    collaborator OTHER

  • Children's Hospital of The Capital Institute of Pediatrics

    collaborator OTHER

  • Beijing Tongren Hospital

    lead OTHER

Principal Investigators

  • Ying Jie · Beijing Tongren Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-26
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05786586 on ClinicalTrials.gov